New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer. The study, published by Cell Press in the July 2nd issue of the journal Cell Stem Cell, describes exciting preclinical studies in which a new therapeutic approach selectively attacks human cancer cells grown in the lab and in animal models of leukemia.
Full article >>
Thursday, July 2, 2009
New targeted therapy finds and eliminates deadly leukemia stem cells
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment